These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37303077)

  • 21. Associations between neck circumference and markers of dysglycemia, non-alcoholic fatty liver disease, and dysmetabolism independent of Body Mass Index in an Emirati population.
    Fojas EGF; Buckley AJ; Lessan N
    Front Endocrinol (Lausanne); 2022; 13():929724. PubMed ID: 36147574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
    Katsiki N; Anagnostis P; Kotsa K; Goulis DG; Mikhailidis DP
    Curr Pharm Des; 2019; 25(18):2051-2059. PubMed ID: 31298151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proportional correlates of adipolin and cathepsin S in metabolic syndrome patients with and without prediabetes.
    Kasabri V; Al-Ghareeb MI; Saleh MI; Suyagh M; Halaseh L; Al-Sarraf I; AlAlawi S
    Diabetes Metab Syndr; 2019; 13(4):2403-2408. PubMed ID: 31405651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a 3-year risk prediction model for developing diabetes in patients with pre-diabetes.
    Yang J; Liu D; Du Q; Zhu J; Lu L; Wu Z; Zhang D; Ji X; Zheng X
    Front Endocrinol (Lausanne); 2024; 15():1410502. PubMed ID: 38938520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining dyslipidaemia, metabolic syndrome and liver enzyme levels in patients with prediabetes and type 2 diabetes in population from Hoveyzeh cohort study: A case-control study in Iran.
    Dinarvand N; Cheraghian B; Rahimi Z; Salehipour Bavarsad S; Bavarsad A; Mohammadtaghvaei N
    Endocrinol Diabetes Metab; 2023 Mar; 6(2):e401. PubMed ID: 36597273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review: chronic viral hepatitis and metabolic derangement.
    Wang CC; Cheng PN; Kao JH
    Aliment Pharmacol Ther; 2020 Jan; 51(2):216-230. PubMed ID: 31746482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
    Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
    Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes.
    Fennoun H; Mansouri SE; Tahiri M; Haraj NE; Aziz SE; Hadad F; Hliwa W; Badr W; Chadli A
    Pan Afr Med J; 2020; 37():270. PubMed ID: 33598084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study.
    Magnussen CG; Koskinen J; Chen W; Thomson R; Schmidt MD; Srinivasan SR; Kivimäki M; Mattsson N; Kähönen M; Laitinen T; Taittonen L; Rönnemaa T; Viikari JS; Berenson GS; Juonala M; Raitakari OT
    Circulation; 2010 Oct; 122(16):1604-11. PubMed ID: 20921439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
    Tofiq KO; Bulatova N; Kasabri V; Suyagh M; Halaseh L; Alalawi S
    Bratisl Lek Listy; 2018; 119(12):762-769. PubMed ID: 30686015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. They’re sicker than we think: an exploratory study profiling the cardio-metabolic health in a sample of adults with pre-diabetes in Aotearoa New Zealand.
    Barthow C; Pullon S; Weatherall M; Krebs J
    J Prim Health Care; 2022 Sep; 14(3):221-228. PubMed ID: 36178844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome and risk of major coronary events among the urban diabetic patients: North Indian Diabetes and Cardiovascular Disease Study-NIDCVD-2.
    Bhatti GK; Bhadada SK; Vijayvergiya R; Mastana SS; Bhatti JS
    J Diabetes Complications; 2016; 30(1):72-8. PubMed ID: 26271411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies.
    Yasin A; Nguyen M; Sidhu A; Majety P; Spitz J; Asgharpour A; Siddiqui MS; Sperling LS; Quyyumi AA; Mehta A
    Diabetes Res Clin Pract; 2024 May; 211():111650. PubMed ID: 38604447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
    Ortiz-Lopez C; Lomonaco R; Orsak B; Finch J; Chang Z; Kochunov VG; Hardies J; Cusi K
    Diabetes Care; 2012 Apr; 35(4):873-8. PubMed ID: 22374640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome.
    Bae JC; Kim SK; Han JM; Kwon S; Lee DY; Kim J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    Diabetes Res Clin Pract; 2017 Jul; 129():136-143. PubMed ID: 28527304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus.
    Cho NH; Ahn CH; Moon JH; Kwak SH; Choi SH; Lim S; Park KS; Metzger BE; Jang HC
    Medicine (Baltimore); 2016 Aug; 95(35):e4582. PubMed ID: 27583868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.
    van Kleef LA; Ayada I; Alferink LJM; Pan Q; de Knegt RJ
    Hepatology; 2022 Feb; 75(2):419-429. PubMed ID: 34453359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
    Franch-Nadal J; Caballeria L; Mata-Cases M; Mauricio D; Giraldez-García C; Mancera J; Goday A; Mundet-Tudurí X; Regidor E;
    PLoS One; 2018; 13(6):e0198327. PubMed ID: 29856820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.